MedTrace Logo

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

NCT07163260 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2025-10-24

No results posted yet for this study

Summary

This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.

Conditions

  • Haemophilia

Interventions

OTHER

No treatment given

No treatment given

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency (dept. 2834) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • India
  • Malaysia
  • South Korea
  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07163260 on ClinicalTrials.gov